The global fight against Lassa fever has recorded another breakthrough as the Oxford Vaccine Group administered the first dose of a new Lassa fever vaccine to a volunteer in the United Kingdom.
The development, announced online on Thursday, took place in Oxford through the Oxford Vaccine Group, a unit of the University of Oxford’s Department of Paediatrics.
The News Agency of Nigeria (NAN) reports that the milestone marks the start of a first-in-human clinical trial of…
Read the full article here
